(Total Views: 270)
Posted On: 04/17/2018 5:26:33 PM
Post# of 72447
I have said for years that I thought that at the root of this attack on IPIX is a big pharma that wants to try to force IPIX into selling assets cheaply. That is not going to happen.
So, when a partnership is made, the incentive to keep pressuring the stock may go away. And, it is going to be impossible to hold the stock down when the company gets a big cash infusion and thus the ability to pick up the Bril-ABSSSI clinical trial, etc., not to mention the fact that the company will suddenly be on the radar of many more investors.
Pity the fools who are holding those 1.2 million legal short shares. Or rather, exult in the destruction of the fools who don't cover as fast as they can.
That's at least a week's worth of normal volume, ya know.
So, when a partnership is made, the incentive to keep pressuring the stock may go away. And, it is going to be impossible to hold the stock down when the company gets a big cash infusion and thus the ability to pick up the Bril-ABSSSI clinical trial, etc., not to mention the fact that the company will suddenly be on the radar of many more investors.
Pity the fools who are holding those 1.2 million legal short shares. Or rather, exult in the destruction of the fools who don't cover as fast as they can.
That's at least a week's worth of normal volume, ya know.
(6)
(0)
